Corcept Therapeutics, Inc. (CORT) Reports In-Line Q4 Loss of 9c/Share

March 7, 2013 5:05 PM

Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q4 EPS of ($0.09) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found